Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹65,486 Cr
Revenue (TTM)
₹6,409 Cr
Net Profit (TTM)
₹1,414 Cr
ROE
35.3 %
ROCE
47.3 %
P/E Ratio
46.3
P/B Ratio
15.5
Industry P/E
37.02
EV/EBITDA
32.4
Div. Yield
1.5 %
Debt to Equity
0
Book Value
₹1992.1
EPS
₹665.6
Face value
10
Shares outstanding
21,249,302
CFO
₹5,829.24 Cr
EBITDA
₹7,612.50 Cr
Net Profit
₹5,845.36 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Abbott India
| 3.5 | -0.7 | 6.4 | 17.6 | 19.7 | 13.4 | 23.2 |
|
BSE Sensex
| 4.4 | 2.7 | 8.5 | 10.1 | 14.6 | 21.7 | 11.3 |
|
BSE Healthcare
| -5.9 | 0.5 | 7.3 | 18.6 | 22.8 | 22.3 | 9.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Abbott India
| 30.7 | 6.9 | 9.7 | 23.7 | 20.0 | 72.5 | 36.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
|
BSE Healthcare
| 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 | -5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Abbott India
|
30,795.0 | 65,486.1 | 6,409.2 | 1,414.4 | 25.3 | 36.5 | 46.3 | 15.5 |
| 5,288.0 | 63,192.5 | 12,756.6 | 2,197.5 | 17.2 | 19.8 | 29.3 | 5.2 | |
| 1,197.1 | 69,490.0 | 30,921.8 | 3,500.3 | 15.8 | 11.8 | 19.9 | 2.2 | |
| 1,484.2 | 1,19,898.3 | 27,547.6 | 5,291.1 | 21.9 | 17.7 | 22.7 | 3.8 | |
| 1,230.1 | 1,02,617.2 | 32,643.9 | 5,703.5 | 20.7 | 17.6 | 18.1 | 3.1 | |
| 1,978.9 | 90,366.7 | 22,707.9 | 3,306.3 | 18.0 | 20 | 27.5 | 5.3 | |
| 2,432.4 | 1,00,456.5 | 12,279.3 | 1,998.9 | 19.6 | 16 | 50.5 | 7.0 | |
| 1,683.6 | 4,03,868.1 | 52,578.4 | 10,980.1 | 23.3 | 16.2 | 37 | 5.6 | |
| 3,174.7 | 1,07,392.1 | 11,516.0 | 1,911.0 | 25.4 | 25.6 | 56.2 | 14.1 | |
| 908.6 | 91,366.1 | 23,241.5 | 4,614.8 | 26.2 | 20.4 | 20.2 | 3.8 |
10 rock-solid stocks with stable earnings
17 min read•By Udhayaprakash, Mithilesh Bhaumik, Shubham Dilawari and Kunal Bansal
Stock Rating update, March 22, 2024
2 min read•By Value Research
2 min read•By Value Research
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, and vaccines, as well as multispecialty... products for insomnia, vitamin D, pre-term labor, and pain management; and anti-infectives, cardio-diabetic, hormones, respiratory, hepatic, consumer care, gastro. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited. Read more
Incorporated
1944
Chairman
Munir Shaikh
Managing Director
Swati Dalal
Group
Abbott India - MNC
Headquarters
Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsRecord Date For Entitlement Of Dividend
15-May-2025Annual General Meeting On August 13 2025
15-May-2025Announcement Under Regulation 30.
30-Apr-2025
The total asset value of Abbott India Ltd stood at ₹ 5,917 Cr as on 31-Mar-25
The share price of Abbott India Ltd is ₹30,795.00 (NSE) and ₹30,818.00 (BSE) as of 23-May-2025 IST. Abbott India Ltd has given a return of 19.71% in the last 3 years.
Abbott India Ltd has a market capitalisation of ₹ 65,486 Cr as on 23-May-2025. As per Value Research classification, it is a Large Cap company.
The P/B ratio of Abbott India Ltd is 15.47 times as on 23-May-2025, a 189% premium to its peers’ median range of 5.35 times.
The P/E ratio of Abbott India Ltd is 46.30 times as on 23-May-2025, a 25% premium to its peers’ median range of 37.02 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Abbott India Ltd and enter the required number of quantities and click on buy to purchase the shares of Abbott India Ltd.
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, and vaccines, as well as multispecialty products for insomnia, vitamin D, pre-term labor, and pain management; and anti-infectives, cardio-diabetic, hormones, respiratory, hepatic, consumer care, gastro. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Capital India Limited.
The prominent promoters of Abbott India Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
ABBOTT CAPITAL INDIA LIMITED |
50.44%
|
|
ABBOTT HEALTHCARE PRODUCTS LIMITED |
17.62%
|
|
BRITISH COLLOIDS LIMITED |
6.92%
|
The chairman of the company is Munir Shaikh, and the managing director is Swati Dalal.
There is no promoter pledging in Abbott India Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
4,03,868
|
|
|
1,19,898
|
|
|
1,07,392
|
|
|
1,02,617
|
|
|
1,00,457
|
|
|
91,366
|
|
|
90,367
|
|
|
69,490
|
|
|
63,192
|
| Abbott India Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
36.48
|
|
Operating margin(%)
|
25.32
|
|
Net Margin(%)
|
21.16
|
|
Dividend yield(%)
|
1.54
|
Yes, TTM profit after tax of Abbott India Ltd was ₹1,414 Cr.
₹-350.00
(
